Search Results

There are 2900 results for: content related to: Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2–6 yr

  1. Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy

    Pediatric Allergy and Immunology

    Volume 17, Issue 8, December 2006, Pages: 620–628, Vasilisa Sazonov-Kocevar, Laurent Laforest, Noemie Travier, Donald D. Yin and Eric Van Ganse

    Article first published online : 24 OCT 2006, DOI: 10.1111/j.1399-3038.2006.00459.x

  2. Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing

    Pediatric Allergy and Immunology

    Volume 25, Issue 2, March 2014, Pages: 143–150, Wan-Sheng Peng, Xin Chen, Xiao-Yun Yang and En-Mei Liu

    Article first published online : 7 OCT 2013, DOI: 10.1111/pai.12124

  3. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children

    Intervention Review

    The Cochrane Library

    Bhupendrasinh F Chauhan and Francine M Ducharme

    Published Online : 16 MAY 2012, DOI: 10.1002/14651858.CD002314.pub3

  4. Clinical efficacy of montelukast in adults and children

    Clinical & Experimental Allergy Reviews

    Volume 1, Issue 3, November 2001, Pages: 264–273, T. F. Reiss, B. Knorr, K. Malmstrom, G. Noonan and S. Lu

    Article first published online : 7 MAY 2002, DOI: 10.1046/j.1472-9725.2001.t01-1-00012.x

  5. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?

    Pediatric Allergy and Immunology

    Volume 17, Issue 4, June 2006, Pages: 259–268, Ozlem Keskin, Evrim Alyamac, Ayfer Tuncer, Cahit Dogan, Gonul Adalioglu and Bulent Enis Sekerel

    Article first published online : 6 JUN 2006, DOI: 10.1111/j.1399-3038.2006.00397.x

  6. You have free access to this content
    Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism

    British Journal of Pharmacology

    Volume 156, Issue 1, January 2009, Pages: 105–115, Ronald Anderson, Annette J Theron, Cornelia M Gravett, Helen C Steel, Gregory R Tintinger and Charles Feldman

    Article first published online : 5 DEC 2008, DOI: 10.1111/j.1476-5381.2008.00012.x

  7. Effects of leukotriene receptor antagonists on monocyte chemotaxis, p38 and cytoplasmic calcium

    Pediatric Allergy and Immunology

    Volume 17, Issue 4, June 2006, Pages: 250–258, Chih-Hsing Hung, Chi-Yuan Li, Yi-Ming Hua, Chun-Jung Chen, Kuender D. Yang and Yuh-Jyh Jong

    Article first published online : 6 JUN 2006, DOI: 10.1111/j.1399-3038.2006.00385.x

  8. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥ 6 years

    Clinical & Experimental Allergy

    Volume 31, Issue 1, January 2001, Pages: 77–87, W. Storms, T. M. Michele, B. Knorr, G. Noonan, G. Shapiro, J. Zhang, S. Shingo and T. F. Reiss

    Article first published online : 9 OCT 2008, DOI: 10.1046/j.1365-2222.2001.00969.x

  9. You have free access to this content
    CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast

    British Journal of Clinical Pharmacology

    Volume 73, Issue 2, February 2012, Pages: 257–267, Tiina Karonen, Pertti J. Neuvonen and Janne T. Backman

    Article first published online : 6 JAN 2012, DOI: 10.1111/j.1365-2125.2011.04086.x

  10. Pharmacokinetics and Safety of Montelukast Oral Granules in Children 1 to 3 Months of Age With Bronchiolitis

    The Journal of Clinical Pharmacology

    Volume 48, Issue 4, April 2008, Pages: 502–511, Dr Gregory L. Kearns, Dr Susan Lu, Dr Lata Maganti, Dr Xiujiang (Susie) Li, Dr Elizabeth Migoya, Ms Tuli Ahmed, Dr Barbara Knorr and Dr Theodore F. Reiss

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008314251

  11. Effect of Citrus Juice and SLCO2B1 Genotype on the Pharmacokinetics of Montelukast

    The Journal of Clinical Pharmacology

    Volume 51, Issue 5, May 2011, Pages: 751–760, Dr E. B. Mougey, Dr J. E. Lang, Ms X. Wen and Dr J. J. Lima

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270010374472

  12. The Targeted Oral, Once-Daily Phosphodiesterase 4 Inhibitor Roflumilast and the Leukotriene Receptor Antagonist Montelukast Do Not Exhibit Significant Pharmacokinetic Interactions

    The Journal of Clinical Pharmacology

    Volume 49, Issue 4, April 2009, Pages: 389–397, Dr Gabriele M. Böhmer, Dr Nassr Nassr, Marcus Wenger, Dr Andreas Hünnemeyer, Gezim Lahu, Dr Silke Templin, Dr Christoph H. Gleiter and Dr Robert Hermann

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008330980

  13. Clinical pharmacology of montelukast

    Clinical & Experimental Allergy Reviews

    Volume 1, Issue 3, November 2001, Pages: 254–260, B. Knorr, S. Holland, J. Schwartz, J. Douglas Rogers and T. F. Reiss

    Article first published online : 7 MAY 2002, DOI: 10.1046/j.1472-9725.2001.t01-1-00011.x

  14. New perspectives for asthma treatment: Anti-leukotriene drugs

    Pediatric Allergy and Immunology

    Volume 10, Issue 2, May 1999, Pages: 77–88, L. Garcia-Marcos and A. Schuster

    Article first published online : 4 JAN 2002, DOI: 10.1034/j.1399-3038.1999.00006.x

  15. Observations on use of montelukast in pediatric eosinophilic esophagitis: insights for the future

    Diseases of the Esophagus

    Volume 24, Issue 4, May 2011, Pages: 229–234, J. Stumphy, D. Al-Zubeidi, L. Guerin, F. Mitros and R. Rahhal

    Article first published online : 12 NOV 2010, DOI: 10.1111/j.1442-2050.2010.01134.x

  16. Pharmacokinetics and Safety of Montelukast in Children Aged 3 to 6 Months

    The Journal of Clinical Pharmacology

    Volume 46, Issue 6, June 2006, Pages: 620–627, Dr Barbara Knorr, Dr Lata Maganti, Dr Rohini Ramakrishnan, Dr Carol A. Tozzi, Dr Elizabeth Migoya and Dr Gregory Kearns

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006288324

  17. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats

    Journal of Pharmacy and Pharmacology

    Volume 63, Issue 4, April 2011, Pages: 550–557, Rui Zhao, Wen-Zhen Shi, Yong-Mei Zhang, San-Hua Fang and Er-Qing Wei

    Article first published online : 1 MAR 2011, DOI: 10.1111/j.2042-7158.2010.01238.x

  18. You have free access to this content
    Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation

    British Journal of Pharmacology

    Volume 160, Issue 6, July 2010, Pages: 1399–1407, K Takeda, Y Shiraishi, S Matsubara, N Miyahara, H Matsuda, M Okamoto, A Joetham and EW Gelfand

    Article first published online : 14 APR 2010, DOI: 10.1111/j.1476-5381.2010.00797.x

  19. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients

    Clinical & Experimental Allergy

    Volume 32, Issue 8, August 2002, Pages: 1180–1186, Y. Tohda, M. Fujimura, H. Taniguchi, K. Takagi, T. Igarashi, H. Yasuhara, K. Takahashi and S. Nakajima

    Article first published online : 19 AUG 2002, DOI: 10.1046/j.1365-2745.2002.01440.x

  20. You have free access to this content
    Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans

    British Journal of Clinical Pharmacology

    Volume 63, Issue 3, March 2007, Pages: 339–345, Kyoung-Ah Kim, Pil-Whan Park, Kyong Rae Kim and Ji-Young Park

    Article first published online : 19 SEP 2006, DOI: 10.1111/j.1365-2125.2006.02764.x